News

According to a recently conducted study in the US, a patch of severe COVID-19 on some children could lead to lasting neurological complications, which is a part of a very rare condition known as multisystem inflammatory syndrome-Children ( MIS-C). These...

A good news is brewing for kids as the COVID-19 vaccine for the age group younger than 5 years old will be made available in the US sooner than expected. With the current scenario, it looks like the vaccine...

Phesi Inc., a data-driven provider of AI-powered clinical development analytics and solutions, has released the results of its global analysis of all clinical trials conducted in 2021. The data show that breast cancer was the most studied disease area,...

AES Clean Technology, a leading provider of high-performance cleanroom facilities within the pharmaceutical and bio-pharmaceutical industry, announced a $14.2 million investment to open a new manufacturing facility located in Manheim Borough, Lancaster County, Pennsylvania. The new state-of-the-art facility will see...

Last year, GlaxoSmithKline’s ViiV Healthcare’s feat of getting a long-awaited approval of HIV treatment by the name of Cabenuva was regarded as a peerless achievement since it eradicated the burden of taking a pill everyday. Another nod a year later...

It doesn’t come as a shock when we hear that GlaxoSmithKline and Gilead Sciences are fighting out in  HIV domain for a long time, just hoping for an access to success over the other, be it new launches or...

Biogen Inc. announced that it exercised its option to participate in the development and commercialization of mosunetuzumab. Biogen will pay a $30 million one-time option fee to Genentech, a member of the Roche Group, as part of the companies’...